Slivka AP - Search Results

1

Noninfective mitral valve vegetations identified by transesophageal echocardiography as a cause of stroke.

Walz ET, Slivka AP, Tice FD, Gray PC, Orsinelli DA, Pearson AC. Walz ET, et al. Among authors: slivka ap. J Stroke Cerebrovasc Dis. 1998 Sep-Oct;7(5):310-4. doi: 10.1016/s1052-3057(98)80048-7. J Stroke Cerebrovasc Dis. 1998. PMID: 17895106

2

Mitral valve strands in patients with focal cerebral ischemia.

Tice FD, Slivka AP, Walz ET, Orsinelli DA, Pearson AC. Tice FD, et al. Among authors: slivka ap. Stroke. 1996 Jul;27(7):1183-6. doi: 10.1161/01.str.27.7.1183. Stroke. 1996. PMID: 8685925

3

Pattern and frequency of recurrent transient ischemic attacks.

Walz ET, Brink T, Slivka A. Walz ET, et al. J Stroke Cerebrovasc Dis. 1997 Jan-Feb;6(3):121-4. doi: 10.1016/s1052-3057(97)80227-3. J Stroke Cerebrovasc Dis. 1997. PMID: 17894982

4

Natural history of nonbacterial thrombotic endocarditis treated with warfarin.

Slivka AP, Agriesti JE, Orsinelli DA. Slivka AP, et al. Int J Stroke. 2021 Jul;16(5):519-525. doi: 10.1177/1747493020961744. Epub 2020 Oct 12. Int J Stroke. 2021. PMID: 33040698

5

Extracranial plasma cell granuloma presenting as a diffuse meningeal and intraparenchymal mass.

Dardas G, Walz ET, Newton HB, Slivka AP. Dardas G, et al. Among authors: slivka ap. J Neuroimaging. 1996 Jan;6(1):58-60. doi: 10.1111/jon19966158. J Neuroimaging. 1996. PMID: 8555666

6

Clinical predictors of cerebrovascular occlusion for patients presenting with acute stroke.

Slivka AP, Notestine MA, Li J, Christoforidis GA. Slivka AP, et al. J Stroke Cerebrovasc Dis. 2006 Jan-Feb;15(1):30-3. doi: 10.1016/j.jstrokecerebrovasdis.2005.08.006. J Stroke Cerebrovasc Dis. 2006. PMID: 17904044

7

Thrombosis in the antiphospholipid-antibody syndrome.

Slivka A, Walz E. Slivka A, et al. N Engl J Med. 1995 Sep 7;333(10):665-6; author reply 666-7. N Engl J Med. 1995. PMID: 7637736 No abstract available.

8

Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.

Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, Mumtaz M, Olsen PS, Heiser JC, Merhi W, Kleiman NS, Chetcuti SJ, Gleason TG, Lee JS, Cheng W, Makkar RR, Crestanello J, George B, George I, Kodali S, Yakubov SJ, Serruys PW, Lange R, Piazza N, Williams MR, Oh JK, Adams DH, Li S, Reardon MJ; SURTAVI Trial Investigators. Van Mieghem NM, et al. JAMA Cardiol. 2022 Oct 1;7(10):1000-1008. doi: 10.1001/jamacardio.2022.2695. JAMA Cardiol. 2022. PMID: 36001335 Free PMC article. Clinical Trial.

9

Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients.

Chou C, Bourekas EC, Slivka A. Chou C, et al. J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1823-1827. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.016. Epub 2016 Apr 25. J Stroke Cerebrovasc Dis. 2016. PMID: 27133771

10

Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis.

Christoforidis GA, Slivka A, Mohammad Y, Karakasis C, Avutu B, Yang M. Christoforidis GA, et al. Stroke. 2007 Jun;38(6):1799-804. doi: 10.1161/STROKEAHA.106.472282. Epub 2007 Apr 26. Stroke. 2007. PMID: 17463318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters